Group One Trading’s Benitec Biopharma BNTC Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTC
IAM
Group One Trading's BNTC Position: Q3 2026 in Review
Group One Trading held its Benitec Biopharma (BNTC) position steady in Q3 2026 at 89 shares worth $890. The position accounts for ﹤0.01% of the portfolio, ranked #7166.
Group One Trading first reported a position in BNTC in Q3 2021 and has held it in 21 quarters since. The position peaked at $7K in Q3 2021. 91 funds tracked by Wall St. Rank hold BNTC as of Q3 2026.
- Group One Trading held 89 shares of Benitec Biopharma worth $890 as of Q3 2026.
- Group One Trading left its Benitec Biopharma share count unchanged in Q3 2026.
- Benitec Biopharma made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #7166 holding.
- Group One Trading first reported a position in Benitec Biopharma in Q3 2021 and has held it in 21 quarters since.
- Group One Trading's Benitec Biopharma position peaked at $7K in Q3 2021.
- 91 funds tracked by Wall St. Rank held Benitec Biopharma as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.